Table 2.

Characteristics of the patients in the 16 included studies [8,12–26].

Study	Patient No.	Age (years)	Type of epilepsy	Follow-up (months)	Research period	Region
Atsina et al., 2016 [26]	23	35±17 (7–66)	MTLE	7days–51	2011–2015	USA
Curry et al., 2012 [12]	5	NA	Lesional and localized epilepsy	2–13	NA	USA
Grewal et al., 2018 [23]	20	43.8±13.9 (22–58)	MTLE	12	2012–2015	USA
Ho et al., 2017 [13]	8	42.1	TLE	>3	2014–2016	USA
Jermakowicz et al., 2017 [14]	23	40.9±11.9	MTLE	12–37	NA	USA
Kang et al. 2015 [8]	20	38.9±16.9	MTLE	6–24	2011–2014	USA
Lewis et al., 2015 [15]	17	15.3 (5.9–20.6)	Lesional and localized epilepsy	3.5–35.9	2011–2014	Canada
Morris et al., 2017 [16]	13	35.5±12.7	Lesional and localized epilepsy	5–8	NA	USA
Perry et al., 2017 [17]	20	13.2±3.9	Insular epilepsy	7–39	2013–2016	USA
Tao et al., 2018 [18]	21	40±13	MTLE	7–43	2014–2017	USA
Vakharia et al., 2018 [24]	25	41.4±17.2	MTS	10.3–38.5	2012–2016	USA
Hena et al., 2015 [19]	7	60 (54–67)	MTLE	12–15.6	NA	USA
Gross and Willie, 2014 [20]	13	24 (16–64)	MTLE	5–26	2011–2013	USA
Yin et al., 2017 [25]	5	45 (28–69)	MTLE	3–9	2015–2015	USA
Youngerman et al., 2018 [21]	30	13 (1–51)	TLE	12–36	2013–2016	USA
Drane et al., 2015 [22]	19	38.2±17.1	TLE	6	NA	USA

MTLE – mesial temporal lobe epilepsy; TLE – temporal lobe epilepsy; MTS – temporal sclerosis; NA – not applicable.